RecruitingNCT05652023

Noninvasive Ultrasound Assessment of Detrusor Dysfunction

Sponsor

Mayo Clinic

Enrollment

2,023 participants

Start Date

Apr 20, 2023

Study Type

OBSERVATIONAL

Conditions

The purpose of this study is to test a new ultrasound method called Quantitative Ultrasound Bladder Vibrometry to detect abnormal bladder function.

Min Age: 18 YearsMax Age: 90 Years

Aim1:
Age \>18 scheduled to undergo UDS for their clinical care for one of the included diagnoses.
Aim2: Inclusions: Age \>45 scheduled to undergo selective photovaporization of the prostate.

Aim1:Obesity (BMI \>35kg/m2), known neurologic disease impacting bladder function (e.g. spinal cord injury, multiple sclerosis, Parkinson's, prior cerebrovascular accident), previous pelvic radiation therapy, previous radical pelvic surgery (such as for uterine or colorectal cancer), prior bladder surgery (including prostate resection), and pregnant or breast-feeding women.
Aim2:Obesity (BMI \>35kg/m2), known neurologic disease impacting bladder function (e.g. spinal cord injury, multiple sclerosis, Parkinson's, prior cerebrovascular accident), previous pelvic radiation therapy, previous radical pelvic surgery (such as colorectal cancer).

Interested in this trial?

Get notified about updates and connect with the research team.

Mayo Clinic

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT05652023